Klaximol (Amoxicillin, Clavulanic Acid)

Amoxicillin interferes with bacterial cell‑wall synthesis by binding to penicillin‑binding proteins, while clavulanic acid inhibits beta‑lactamase enzymes that some bacteria produce to inactivate amoxicillin. This combination broadens the antibacterial spectrum and enhances bacterial killing.

The dosage of Klaximol is individualized by the prescribing clinician based on the infection type, severity, patient age, weight, and renal function. Healthcare providers determine the appropriate strength, frequency, and duration of therapy.

Safety data for amoxicillin/clavulanic acid in pregnancy are limited, and the product is classified as pregnancy category unknown. It should be used only when clearly needed, after weighing potential benefits against risks. Breastfeeding mothers should consult their physician, as small amounts may be excreted in milk.

To place an order, submit an enquiry on the Klaximol product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Klaximol combines amoxicillin with clavulanic acid, offering protection against beta‑lactamase‑producing bacteria that can inactivate amoxicillin alone. This broader spectrum makes it useful for infections where resistance mechanisms are suspected, whereas plain amoxicillin may be sufficient for beta‑lactamase‑negative organisms.

Klaximol tablets should be stored at ambient temperature, preferably below 25 °C. Keep them in the original blister pack, protect from moisture and direct sunlight, and ensure the container is tightly closed to maintain product stability.

Klaximol is taken orally, usually with a full glass of water. It can be taken with or without food, but consistency with meals may reduce gastrointestinal upset. Patients should follow the prescribing clinician’s instructions regarding timing and duration.

Serious adverse reactions include anaphylaxis, Stevens‑Johnson syndrome, severe hepatic injury, and Clostridioides difficile‑associated colitis. Any signs of severe rash, difficulty breathing, jaundice, or persistent diarrhea warrant immediate medical attention.

Klaximol is contraindicated in individuals with a known hypersensitivity to amoxicillin, clavulanic acid, or other beta‑lactam antibiotics. Patients with a history of severe allergic reactions to penicillins should avoid this medication.